Spotlight On

Guest: Ilene Galinsky BSN,MSN,ANP-C Here to review the ramp-up and dosing for venetoclax therapy in patients with newly diagnosed acute myeloid leukemia is Ilene Galinsky, Senior Program Research Nurse Practitioner for the Leukemia Program at Dana Farber Cancer Institute.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Harry Paul Erba, MD, PhD Guest: Uma Borate, MD, MS With the development of technologies paired with an enhanced understanding of the AML genomic landscape, it’s become possible to further the development of AML therapies. Joining Dr. Charles Turck to explore venetoclax and its role in current AML treatment paradigms are Drs. Uma Borate and Harry Erba.

Guest: Harry Paul Erba, MD, PhD Although survival among younger patients with acute myeloid leukemia (AML) has improved over the past decade, older patients continue to have a poor prognosis. And since age and frailty are the primary predictors of outcome among patients with AML, Dr. Harry Erba shares how the treatment of older patients with AML may be changing. BCL2-US-00027-MCVersion 2.0, Approved November 2020

Guest: Harry Paul Erba, MD, PhD For several decades, therapy for acute myeloid leukemia (AML) was rather straightforward. But now that we have a deeper understanding of the pathogenesis of AML, this has led to the identification of potential therapeutic targets that give us options in addition to standard intensive chemotherapy, as Dr. Harry Erba explains. BCL2-US-00026-MCVersion 2.0, Approved November 2020

Guest: Matthew S. Davids, MD, MMSc In addition to complete response, some clinical trials are also using minimal residual disease (MRD) to measure depth of response in chronic lymphocytic leukemia. But how exactly is MRD being defined and discussed in CLL? Here to answer that question and more is Dr. Matthew Davids, Associate Professor of Medicine at Harvard Medical School and Associate Director of the Center for Chronic Lymphocytic Leukemia at Dana-Farber Cancer Institute in Boston,...

Guest: MeiLan K. Han, MD, MS For patients with COPD, exacerbations can have an irreversible and sustained impact on their daily life.3,4 Additionally, exacerbations are often underreported.5 That’s why Dr. MeiLan Han is here to walk us through the importance of exacerbation recognition and prevention, the health and life burdens of exacerbations, and patient-physician communication gaps. References: Halpin DMG, Decramer M, Celli BR, et al. Effect of a single exacerbation on decline in lung...

Host: Matt Birnholz, MD Guest: Sanjay Chabra, MD As stated by Dr. Sanjay Chabra, "About 19 percent of the population lives with chronic back pain, but what about when it’s inflammatory—not mechanical—back pain?" Join Dr. Matt Birnholz as he sits down with Dr. Chabra at the 2019 American College of Rheumatology annual meeting in Atlanta, Georgia, to share strategies that can help us shorten the delay in the diagnosis of ankylosing spondylitis that often occurs within and around rheumatology...

Host: Matt Birnholz, MD Guest: Roger Kornu, MD To help address the gap in awareness across the field regarding the development of psoriatic arthritis, Dr. Roger Kornu joins Dr. Matt Birnholz at the 2019 American College of Rheumatology annual meeting in Atlanta, Georgia, to discuss commonly overlooked symptoms, including plaque psoriasis, dactylitis, and enthesitis. PP-IX-US-3710 04/2020 ©Lilly USA, LLC 2020. All rights reserved.

Host: Matt Birnholz, MD Guest: Smitha Reddy, MD Join Dr. Matt Birnholz as he sits down with Dr. Smitha Reddy at the annual rheumatology meeting in Atlanta, Georgia to explore how an anti-inflammatory diet could have an impact on a rheumatoid arthritis patient's lifestyle. PP-BA-US-1149 2/2020 ©Lilly USA, LLC 2020. All rights reserved.

Host: Matt Birnholz, MD Guest: Ara Dikranian, MD Did you know joint stiffness and tenderness as well as joint pain could be early signs and symptoms of rheumatoid arthritis? Once symptoms are identified, how do you know which patients should be referred to a rheumatologist? Answering those and other questions is Dr. Ara Dikranian, who sat down with Dr. Matt Birnholz at the annual rheumatology meeting in Atlanta, Georgia. PP-BA-US-1143 2/2020 ©Lilly USA, LLC 2020. All rights reserved.

Host: Paul Doghramji, MD Guest: David H. Peyton, Ph.D. The vaping epidemic is becoming more and more concerning, but could new research prompt people to quit? To find out, Dr. Paul Doghramji speaks with Dr. David Peyton about his recent study that challenges the claim that vaping devices take less of a toll on our health than tobacco smoking.

Host: Sergio Schwartzman, MD Guest: Stephen Hanauer, MD Even though there’s a known relationship between inflammatory bowel disease (IBD) and spondyloarthritis, not all arthropathies associated with IBD signal spondyloarthritis. So how can gastroenterologists and rheumatologists work together to identify and manage those that are? That’s what rheumatologist Dr. Sergio Schwartzman breaks down with Dr. Stephen Hanauer, Medical Director of the Digestive Health Center at Northwestern...

Host: Sergio Schwartzman, MD Guest: Michael Payette, MD, MBA, FAAD Patients with spondyloarthritis can experience a wide range of dermatologic manifestations ranging from psoriasis to erythema nodosum, making collaborative care between rheumatologists and dermatologists essential. Here to talk about how rheumatologists like Dr. Sergio Schwartzman can manage and refer patients with spondyloarthritis to dermatologists—and vice versa—is Dr. Michael Payette, co-founder of Central Connecticut...

Host: Jennifer Caudle, DO Guest: Sergio Schwartzman, MD Since primary care physicians are on the frontlines of healthcare, they play an important role in not only diagnosing and managing patients with spondyloarthritis, but also referring those patients to rheumatologists when appropriate. Here to walk through what primary care physicians should consider is rheumatologist Dr. Sergio Schwartzman. This activity is intended for United States and Puerto Rico health care professionals only.

Host: Sergio Schwartzman, MD Guest: Jennifer Thorne, MD, PhD Did you know that more than 20 percent of patients with spondyloarthritis experience at least one episode of uveitis? Or that nearly half of patients with uveitis may also have undiagnosed spondyloarthritis? That’s why co-managed care is so important for these patients, as rheumatologist Dr. Sergio Schwartzman and ophthalmologist Dr. Jennifer Thorne explain. This activity is intended for United States and Puerto Rico health care...

Host: Matt Birnholz, MD Guest: Michael McKee, MD, FRCS(C) Diagnosing and treating nonunion fractures comes with its set of challenges. Fortunately, Dr. Michael McKee is here to share his expertise and recommendations for success to benefit your patients with nonunion fractures.

Host: Matt Birnholz, MD Guest: Michael R Redler, MD Guest: Ryan Riggs, MD Osteoarthritis is a progressive joint disease that affects millions worldwide, and with incidence rates continuing to climb due to a longer-living population and an increase in obesity, staying up to date on the latest treatment approaches is essential. Join Drs. Michael Redler and Ryan Riggs as they discuss the current treatment landscape for osteoarthritis and what's on the horizon for this growing problem.

Host: Chris Panebianco Guest: Roger Wohlner Don’t just run your practice with the mindset of a healthcare provider—run it as a business. Listen in as Bankers Healthcare Group’s Chief Marketing Officer Chris Panebianco speaks with Roger Wohlner about how to plan for a successful future for your practice. Wohlner started The Chicago Financial Planner blog to share his knowledge and experiences as a financial advisor. His goal is to provide ideas to readers in the hope of guiding them to...

Host: Keith W. Gruebele Guest: Gene Marks Unsure of how to plan ahead financially or how to prepare for unexpected expenses? Covering all this and more with Keith W. Gruebele is Gene Marks. A small business expert and CPA, Marks writes daily for The Washington Post, focusing on issues affecting the business community. He also writes for Forbes, Inc., Fox Business, The Huffington Post, and Entrepreneur.com.

Host: Chris Panebianco Guest: Earl Anderson With more and more physicians moving towards hospitals, what exactly does this mean for private practices? Joining Bankers Healthcare Group’s Chief Marketing Officer Chris Panebianco to offer living proof that independent practices can in fact thrive amid this trend is Earl Anderson. Anderson has worked in orthopedics for more than 30 years as a clinician and administrator in both private physician practice and hospital settings. Since starting...